05/23/2023: Researchers led by Dr. Xavier Intes from Rensselaer Polytechnic Institute (RPI) and Dr. Margarida Barroso from Albany Medical College were awarded a $3.3 million grant over five years by the National Cancer Institute to use artificial intelligence (AI) to improve targeted drug therapy in HER2-positive breast cancer treatment.